India Biologics Market (2024-2030) | Forecast, Trends, Industry, Share, Revenue, Growth, Value, Size, Outlook, Companies & Analysis

Market Forecast By Source (Microbial, Mammalian, Others), By Product Type (Monoclonal Antibodies, Vaccines, Recombinant Proteins, Antisense, RNAi, & Molecular Therapy, Others), By Diseaseย  Category (Oncology, Infectious Diseases, Immunological Disorders, Cardiovascular Disorders, Hematological Disorders, Others), By Biologics Manufacturing (Outsourced, In-house) And Competitive Landscape
Product Code: ETC052444 Publication Date: Jun 2023 Updated Date: Jan 2024 Product Type: Report
Publisher: 6Wresearch No. of Pages: 70 No. of Figures: 35 No. of Tables: 5

India Biologics Market Synopsis

The India biologics market is estimated to grow at a CAGR of 10.8% during the forecast period 2020-2026. Biologic drugs are derived from living organisms, such as proteins, nucleic acids and microorganisms, or parts thereof. They are generally used for treating serious health conditions in humans such as cancer and autoimmune diseases. Rising prevalence of chronic diseases along with increasing investments by major players for developing novel biologics products will drive the growth of Indian biologics market over the forecast period.

Drivers of the Market:

Increasing Prevalence Of Chronic Diseases: The increasing prevalence of chronic diseases such as diabetes, cardiovascular disorders and cancer has propelled the demand for new therapeutic agents that can treat these conditions effectively which in turn is anticipated to boost the overall growth of India?s biologic drug market over the coming years. Rapidly Developing Healthcare Infrastructure: India has witnessed huge developments in its healthcare infrastructure over past few years due to rising public spending on healthcare facilities which also includes increased focus towards development and manufacturing capabilities related to biosimilars production technology providing an impetus to this industry`s growth prospects overtime. Growing Investments By Major Players For Novel Drug Development: Pharmaceutical companies have been actively investing in research & development activities for discovering innovative molecules as well as focusing on expanding their product portfolio leading towards strong competition among players present in this space thus driving up overall market size significantly during foreseeable future too.

Challenges of the Market:

) High Cost Of Manufacturing Biosimilar Drugs In India: The cost associated with manufacturing biosimilar drugs is very high owing primarily due to complex recombinant cell line development process involved making it difficult even for large scale manufacturers who need access capital investment funds given current economic environment across country limiting number possible entrants into industry thereby creating supply side constraints ahead expected near term horizon further hampering potential upside potential heretofore seen till date clearly then indicating limitations posed currently upon sectoral performance going forward henceforth accordingly without any doubts whatsoever conclusively indeed! Lack Of Regulations And Guidelines For Biosimilars Production In India: Despite government initiatives taken recently like setting up National Biopharma Mission (NBM), there still exists lack regulatory framework governing production processes related these drugs including control quality standards same implying insufficient awareness amongst medical professionals about use them safely efficiently causing fatigue clinic trials delays approvals hindering prospective uptick sales revenues projected within specified timeframe constrained range instead being wider than initially.

Key Highlights of the Report:

  • India Biologics Market Outlook
  • Market Size of India Biologics Market, 2023
  • Forecast of India Biologics Market, 2030
  • Historical Data and Forecast of India Biologics Revenues & Volume for the Period 2020-2030
  • India Biologics Market Trend Evolution
  • India Biologics Market Drivers and Challenges
  • India Biologics Price Trends
  • India Biologics Porter's Five Forces
  • India Biologics Industry Life Cycle
  • Historical Data and Forecast of India Biologics Market Revenues & Volume By Source for the Period 2020-2030
  • Historical Data and Forecast of India Biologics Market Revenues & Volume By Microbial for the Period 2020-2030
  • Historical Data and Forecast of India Biologics Market Revenues & Volume By Mammalian for the Period 2020-2030
  • Historical Data and Forecast of India Biologics Market Revenues & Volume By Others for the Period 2020-2030
  • Historical Data and Forecast of India Biologics Market Revenues & Volume By Product Type for the Period 2020-2030
  • Historical Data and Forecast of India Biologics Market Revenues & Volume By Monoclonal Antibodies for the Period 2020-2030
  • Historical Data and Forecast of India Biologics Market Revenues & Volume By Vaccines for the Period 2020-2030
  • Historical Data and Forecast of India Biologics Market Revenues & Volume By Recombinant Proteins for the Period 2020-2030
  • Historical Data and Forecast of India Biologics Market Revenues & Volume By Antisense, RNAi, & Molecular Therapy for the Period 2020-2030
  • Historical Data and Forecast of India Biologics Market Revenues & Volume By Others for the Period 2020-2030
  • Historical Data and Forecast of India Biologics Market Revenues & Volume By Disease? Category for the Period 2020-2030
  • Historical Data and Forecast of India Biologics Market Revenues & Volume By Oncology for the Period 2020-2030
  • Historical Data and Forecast of India Biologics Market Revenues & Volume By Infectious Diseases for the Period 2020-2030
  • Historical Data and Forecast of India Biologics Market Revenues & Volume By Immunological Disorders for the Period 2020-2030
  • Historical Data and Forecast of India Biologics Market Revenues & Volume By Cardiovascular Disorders for the Period 2020-2030
  • Historical Data and Forecast of India Biologics Market Revenues & Volume By Hematological Disorders for the Period 2020-2030
  • Historical Data and Forecast of India Biologics Market Revenues & Volume By Others for the Period 2020-2030
  • Historical Data and Forecast of India Biologics Market Revenues & Volume By Biologics Manufacturing for the Period 2020-2030
  • Historical Data and Forecast of India Biologics Market Revenues & Volume By Outsourced for the Period 2020-2030
  • Historical Data and Forecast of India Biologics Market Revenues & Volume By In-house for the Period 2020-2030
  • India Biologics Import Export Trade Statistics
  • Market Opportunity Assessment By Source
  • Market Opportunity Assessment By Product Type
  • Market Opportunity Assessment By Disease? Category
  • Market Opportunity Assessment By Biologics Manufacturing
  • India Biologics Top Companies Market Share
  • India Biologics Competitive Benchmarking By Technical and Operational Parameters
  • India Biologics Company Profiles
  • India Biologics Key Strategic Recommendations
Frequently Asked Questions About the Market Study (FAQs):
6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 India Biologics Market Overview

3.1 India Country Macro Economic Indicators

3.2 India Biologics Market Revenues & Volume, 2020 & 2030F

3.3 India Biologics Market - Industry Life Cycle

3.4 India Biologics Market - Porter's Five Forces

3.5 India Biologics Market Revenues & Volume Share, By Source, 2020 & 2030F

3.6 India Biologics Market Revenues & Volume Share, By Product Type, 2020 & 2030F

3.7 India Biologics Market Revenues & Volume Share, By Diseaseย  Category, 2020 & 2030F

3.8 India Biologics Market Revenues & Volume Share, By Biologics Manufacturing, 2020 & 2030F

4 India Biologics Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.3 Market Restraints

5 India Biologics Market Trends

6 India Biologics Market, By Types

6.1 India Biologics Market, By Source

6.1.1 Overview and Analysis

6.1.2 India Biologics Market Revenues & Volume, By Source, 2020-2030F

6.1.3 India Biologics Market Revenues & Volume, By Microbial, 2020-2030F

6.1.4 India Biologics Market Revenues & Volume, By Mammalian, 2020-2030F

6.1.5 India Biologics Market Revenues & Volume, By Others, 2020-2030F

6.2 India Biologics Market, By Product Type

6.2.1 Overview and Analysis

6.2.2 India Biologics Market Revenues & Volume, By Monoclonal Antibodies, 2020-2030F

6.2.3 India Biologics Market Revenues & Volume, By Vaccines, 2020-2030F

6.2.4 India Biologics Market Revenues & Volume, By Recombinant Proteins, 2020-2030F

6.2.5 India Biologics Market Revenues & Volume, By Antisense, RNAi, & Molecular Therapy, 2020-2030F

6.2.6 India Biologics Market Revenues & Volume, By Others, 2020-2030F

6.3 India Biologics Market, By Diseaseย  Category

6.3.1 Overview and Analysis

6.3.2 India Biologics Market Revenues & Volume, By Oncology, 2020-2030F

6.3.3 India Biologics Market Revenues & Volume, By Infectious Diseases, 2020-2030F

6.3.4 India Biologics Market Revenues & Volume, By Immunological Disorders, 2020-2030F

6.3.5 India Biologics Market Revenues & Volume, By Cardiovascular Disorders, 2020-2030F

6.3.6 India Biologics Market Revenues & Volume, By Hematological Disorders, 2020-2030F

6.3.7 India Biologics Market Revenues & Volume, By Others, 2020-2030F

6.4 India Biologics Market, By Biologics Manufacturing

6.4.1 Overview and Analysis

6.4.2 India Biologics Market Revenues & Volume, By Outsourced, 2020-2030F

6.4.3 India Biologics Market Revenues & Volume, By In-house, 2020-2030F

7 India Biologics Market Import-Export Trade Statistics

7.1 India Biologics Market Export to Major Countries

7.2 India Biologics Market Imports from Major Countries

8 India Biologics Market Key Performance Indicators

9 India Biologics Market - Opportunity Assessment

9.1 India Biologics Market Opportunity Assessment, By Source, 2020 & 2030F

9.2 India Biologics Market Opportunity Assessment, By Product Type, 2020 & 2030F

9.3 India Biologics Market Opportunity Assessment, By Diseaseย  Category, 2020 & 2030F

9.4 India Biologics Market Opportunity Assessment, By Biologics Manufacturing, 2020 & 2030F

10 India Biologics Market - Competitive Landscape

10.1 India Biologics Market Revenue Share, By Companies, 2023

10.2 India Biologics Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Related Reports

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All